BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Amniocentesis
,
Rapamycin
,
rs2476601
,
PDX1
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
farnesyltransferase inhibitor
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Fibroblasts overexpressing prelamin A/progerin + treated with farnesyltransferase inibitor L-744832
Bone marrow from AML patients responsive or non-responsive to tipifarnib
Explore Curated Studies Results
Literature
Most Relevant Literature
Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regul…
Effect of p21Ras in vitro intervention on the phenotype of airway smooth muscle cells from asthmatic…
FPTIII mitigates peroxisome-mediated oxidative stress in kidneys of spontaneously hypertensive diabe…
Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypert…
Carbohydrate analysis of Acanthamoeba castellanii.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)
A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) I…
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ